Cargando…
NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
BACKGROUND: Even though two NTRK-targeting drugs are available for the treatment of irresectable, metastatic, or progressive NTRK-positive solid tumors, less is known about the role of NTRK fusions in lymphoma. For this reason, we aimed to investigate if NTRK fusion proteins are expressed in diffuse...
Autores principales: | Ghandili, Susanne, Dierlamm, Judith, Bokemeyer, Carsten, von Bargen, Clara Marie, Weidemann, Sören Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043297/ https://www.ncbi.nlm.nih.gov/pubmed/36998460 http://dx.doi.org/10.3389/fonc.2023.1146029 |
Ejemplares similares
-
EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma
por: Akyüz, Nuray, et al.
Publicado: (2023) -
Case Report: Identification of a novel NTRK3-AJUBA fusion co-existing with ETV6-NTRK3 fusion in papillary thyroid carcinoma
por: Yu, Qing-Xiang, et al.
Publicado: (2023) -
Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
por: Zhang, Jun, et al.
Publicado: (2018) -
NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma
por: Wang, Yuekun, et al.
Publicado: (2020) -
Secondary Diffuse Large B-cell Lymphoma Mimicking Meningioma
por: Garcia-Grimshaw, Miguel, et al.
Publicado: (2019)